- Research article
- Open Access
Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study
BMC Research Notes volume 6, Article number: 89 (2013)
Nonalcoholic fatty liver disease (NAFLD) related to obesity has been rising in the last decades, though the morphological and metabolic determinants are remain unclear in children. The aim of this study was to analyze the morphological determinants and metabolic abnormalities in obese children and adolescents, classified either as with (P-NAFLD) or without (N-NAFLD). The sample comprised 190 individuals, aged 6 to 16 years-old, assigned into one of 4 groups according to sex and presence or absence of NAFLD. Obesity was obtained according to body mass index (BMI) cut-points. Body composition variables was estimated by Dual-Energy X-ray Absorptiometry (DEXA). Total cholesterol (TC), triglycerides (TG), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), insulin, fasting glucose (FG) and blood pressure were also analyzed. The diagnosis of NAFLD, as well as the measurement of intra-abdominal fat tissue thickness (IAF) and subcutaneous abdominal fat tissue thickness (SCF), was carried-out by ultrasound.
Males and females belonging to P-NAFLD group showed, respectively, higher TFM and IAF. When data were adjusted for sex, age and total fat mass, those in P-NAFLD showed statistically higher IAF, TFM and TG.
Our study showed that obese youngsters who were assigned to P-NAFLD group were twice as likely to present higher concentration of triglycerides, higher levels of trunk fat, as well as intra-abdominal fat compared to their N-NAFLD counterparts even after adjustments for sex, age, pubertal stage and total body fat mass.
Nonalcoholic fatty liver disease (NAFLD) or liver steatosis is characterized by a pathological fat accumulation in the liver, ranging from simple steatosis to non-alcoholic steatohepatitis, advanced fibrosis, cirrhosis and liver cancer.
Although the prevalence of NAFLD is not well known, it is the most common form of pediatric liver disease. Fat accumulation in the liver, mainly in the triglycerides form, can range from5 to 10% of the liver weight[2, 3] and studies have shown a strong association between obesity and NAFLD. With increasing obesity rates globally, NAFLD is considered a growing public health concern. The pathogenesis of NAFLD is complex and comprises multiple factors such as genetic predisposition, life style, visceral adiposity, insulin resistance, ethnicity, age and sex[6, 7]. Some studies indicate that the histopathological signs of steatosis can appear between 11 and 13 years, for both sexes. This timing suggests that puberty may play an important role inthe development of this pathology due to the increased production of sex hormones and insulin resistance, which might be crucial to NAFLD genesis.
Although obese individuals are more prone to present NAFLD, data regarding the differences in clinical manifestation and related metabolic abnormalities in those with and without NAFLD diagnosis is scarce. To the best of our knowledge there is only one study in Brazil that has addressed this issue so far, having examined the body composition and metabolic profile in young obese with NAFLD diagnosis in post-apex pubertal stage. However, the data were not analyzed according to maturational stage and did not indicate whether or not fat distribution and cardio-metabolic profile are associated NAFLD. To fill this gap in the literature, our study aimed to analyze the association between NAFLD and morphological determinants in a sample of Brazilian obese youngsters.
Participants and setting
Data of 190 obese children and adolescents, aged 6 to 16 years old, were collected during the second semester of 2010. The participants were invited, through media advertisement, to participate in a community-based program. This program aimed to treat obesity focused on enhancing exercise and nutritional orientation and was carried out at facilities of the Universidade Estadual Paulista - Campus of Presidente Prudente (FCT/UNESP), São Paulo, Brazil.
The inclusion criteria were: (a) to be classified as obese according to the reference values proposed by Cole et al., (b) aged between 6 and 16 years at the first evaluation date, and (c) participants and parents/guardians signed a written informed consent form for the participation in the program.
The Ethical Committee of FCT/UNESP approved this study (Protocol number 07/2009).
Body weight (BW) was measured with an electronic scale (precision 0.1 kg [Filizzola PL 150, Filizzola Ltda]) and the height (H) with a wall-mounted stadiometer (precision 0.1 cm [Sanny®, São Paulo, Brazil]). Both measurements were carried out with participants wearing light clothing and no shoes. Body mass index (BMI) was then calculated as kg/m2. All anthropometric measurements were performed by trained researchers, according to standardized techniques.
Dual Energy X-Ray Absorptiometry
Body composition was estimated by a Dual-energy X-ray absorptiometry (DEXA) scanner (Lunar DPX-NT; General Electric Healthcare, Little Chalfont, Buckinghamshire), with software version 4.7. The method estimated the body composition by fractionating the body into three anatomical compartments: fat-free mass (FFM), fat mass (FM) and bone mineral content. The assessment was carried out in approximately 15 minutes, and the subjects remained still and in a supine position throughout the scan, wearing light clothing while lying flat on their back with arms by the side. The results were expressed in kilograms of FFM and FM. The absolute (kg) and relative (%) values from trunk fat (%TF) were also assessed by DEXA. All DEXA measurements were carried-out at the University laboratory in a controlled temperature room. Each morning, before the beginning of the measurements, the DEXA was calibrated by the same researcher, according to the references provided by the manufacturer.
Stages of puberty
The stage of puberty was self-assessed by the participants aged older than 10 years. A standardized series of drawings was given to the subjects to assess their own pubertal development. Girls received drawings of the five stages of Tanner breast and female pubic hair development with appropriate descriptions accompanying the drawings. Boys were given line drawings of boys showing the five Tanner stages of pubic hair development, with appropriate written descriptions. Participants were asked to select the drawing of the stage that best indicated his other own development. All procedures were done as described by Marshall & Tanner. The results were placed by each subject in a locked box with only their subject id as an identifier, so as to guarantee the integrity and anonymity of the subjects. Only the main researcher had access to those questionnaires.
The breast stages for girls and genitalia stages for boys were chosen to classify the sexual maturation status because they are recommended by a World Health Organization Expert Committee as indicators of sexual maturation for international use. The original five pubertal stages were grouped in three new groups: participants aged under 10 years and those who answered stage 1, were grouped in group 1; those who answered stages 2 and 3, were grouped in group 2; and those who answered stages 4 and 5, were grouped in group 3.
The ultrasound equipment (Toshiba Aplio Model Tochigi-ken, Japan) was used by a trained radiologist to assess the level of fat accumulation and the morphology of the liver. Finally the NAFLD diagnosis was made by a hepatologist. The NAFLD was graded semi qualitatively as described by Shannon: Score 0 is absence of steatosis, defined as normal liver echo texture; Score 1 is mild steatosis, defined as slight and diffuse increase in fine parenchymal echoes, normal visualization of diaphragm and portal vein borders; Score 2 is moderate steatosis, defined as a diffuse increase in fine echoes with slightly impaired visualization of diaphragm and portal vein borders and; Score 3 is severe steatosis, defined as fine echoes with poor or no visualization of diaphragm, portal vein borders and posterior portion of the right lobe. The participants were labeled as “without NAFLD” (N-NAFLD) and those with any of the above mentioned grade of fatty infiltration in the liver were labeled as “with NAFLD” (P-NAFLD).
The ultrasound is an image evaluation that provides diagnosis of NAFLD and measures, in centimeters, the length of intra-abdominal fat (IAF) and subcutaneous fat (SCF).
A 12-hour fasting blood sample collection was taken and analyzed by a private laboratory located in the city of Presidente Prudente, Brazil. Samples were collected in vacuum tubes containing gel with anticoagulant. Then the blood was centrifuged for 10 minutes at 3,000 rpm. To measure total cholesterol (TC), triglyceride (TG), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C) and glucose (GL), an enzymatic colorimetric kit processed in a unit Autohumalyzer A5 was used. Insulin was analyzed using the RayBio® Human Insulin ELISA Kit, following the Manual Revised Nov 23, 2009.
An automated digital blood pressure monitor (Omron Healthcare, Inc., Intellisense, modelo HEM 742 INT, Bannockburn, Illinois, USA) was used for the measurement of systolic (SBP) and diastolic (DBP) blood pressure. This equipment was previously validated for pediatric population. After fifteen minutes of resting in a lying-down position, two measures were taken on the right arm, with a two minute interval between them. The mean value was used for statistical analysis.
Diagnosis of metabolic syndrome
For diagnosis of Metabolic Syndrome (MS), we adopted the cut-point proposed by the World Health Organization (WHO) for adolescents. The MS was diagnosed in subjects who presented three or more of the following risk factors: Obesity (BMI > percentile 95 according Must); Glucose Homeostasis (prepubertal hyperinsulinemia >15 mU/L; [stage 1 Tanner] pubertal>30 mU/L; [stages 2–4 Tanner] pospubertal ≥20 mU/L [stage 5 Tanner]; Fasting Glucose ≥6.1mM/L and Impaired Glucose Tolerance: 120min ≥ 7.8mM/L), Elevated Blood Pressure (SBP > perc95 for age, sex and height proposed by NHBPEP). Dyslipidemia (Triglycerides >105mg/dL for children< 10 years and >136mg/dL for children ≥ 10 years, HDL-C <35 mg/dL and Total Cholesterol > percentile 95).
Descriptive data are shown as means and standard deviation. One-way analysis of variance (ANOVA) was applied to analyze the differences in body composition, blood pressure and biochemical variables between males and females within NAFLD groups. A multivariate analysis was used to compare all variables within NAFLD group as dependent variable. Data were adjusted for sex, age, pubertal stage and total fat mass. The relative risk (odds ratio) and 95% confidence interval were calculated by binary logistic regression. The statistical significance was set at 5% for all the analyses and the calculations were conducted using SPSS, version 17.0 (SPSS Inc. Chicago. IL).
Table 1 shows general characteristics and comparisons of morphological and metabolic risk factors, according to sex, as well aspresence and absence of NAFLD. Among children and adolescents evaluated in this study, 18.7% (n = 35) had metabolic syndrome and 25.7% (n = 48) had DGNAF. Of youth with DGNAF, 9.1% (n = 17) also had syndrome metabolic. The comparisons showed statistical differences in the BW (p=0.003), FM (p=0.042), FFM (p<0.001) and SBP (p=0.039) between males and females, respectively, with and without NAFLD; BMI (p=0.001) between males with and without NAFLD; FG (p<0.001) between females with and without NAFLD, and in the TFM (p=0.002) between males with and both sexes without NAFLD.
In Table 2 illustrates the multivariate analysis findings. After adjustments for sex, age, pubertal stage and total body fat mass, statistically significant differences were observed in TG (p=0.036), TFM (p=0.001) and IAF (P=0.002) for both NAFLD groups.
Table 3 shows the findings of regression analysis in which only those variables that showed statistical significance were incorporated into the model. Males of P-NAFLD group were more likely to have higher levels of %TF above median value (46.62%) while P-NAFLD females were more likely to show IAF values above median (3.75cm).
The purpose of the present study was to analyze the morphological determinants and metabolic abnormalities in obese children and adolescents, classified according to positive or negative diagnosis to NAFLD.
The main results of the present study are that gender differences seem to be associated with NAFLD in obese youth. Indeed, P-NAFLD males were more likely to have higher levels of abdominal fat mass, while P-NAFLD females were more likely to show higher intra-abdominal fat mass. Our data are noteworthy. Indeed, the relationship between obesity and NAFLD in children was also observed in a recent study. Additionally, obese individuals are often afflicted with comorbidities caused by obesity, such as NAFLD[20, 21], that can evolve to more damaging stages as cirrhosis and liver carcinoma.
In pediatric populations, previous studies have reported that NAFLD is related to risk factors such as: whole body and central obesity[6, 22], insulin resistance and type II diabetes. Studies also suggest that children who enter puberty with excessive fat and/or present genetic basis are more likely to develop NAFLD[8, 24]. Nonetheless, the amount of fat accumulated in the deep abdominal region seems to be a key-factor in NAFLD diagnosis. Furthermore, the profound endocrine, metabolic and morphologic changes that occurred over time, particularly in adolescence might explain the gender differences found in the occurrence of NAFLD.
Indeed, despite the effect of estrogen hormone, which stimulates accumulation of fat in the hip area and contributes towards the cardiovascular risk events decrease in women[26–28], as well as provides a protective effect on the accumulation of fat in the liver, our results indicate that a small increase in the amount of IAF in girls is associated with P-NAFLD, independently of total fat mass, sex, pubertal stage and age.
These findings are consistent with those obtained in previous studies[29, 30], suggesting that visceral adiposity is the best variable for predicting the fat accumulation in the liver, with a further possible explanation for the differences between sex, being related to sex hormones during puberty.
The discovery of the possible link between biological mechanisms responsible for the changes in body fat distribution, in both males and females, from childhood to adolescence, as well as the incidence of NAFLD, seems to be a key factor deserving of further attention so as to improve the prevention and treatment of NAFLD in clinical and epidemiological settings.
Despite these important findings which indicate that body fat in the trunk area is associated with NAFLD, especially in males, and that females seems to be more sensitive to develop NAFLD with the same amount of intra-abdominal fat them males. The main limitation of the present study were the use of ultrasound as the only method for diagnosis of NAFLD, without confirmation by liver function enzymes.
In conclusion, the higher concentration of trunk fat and intra-abdominal fat, in obese adolescents may indicate potential to elevate the risk of developing nonalcoholic fat liver disease even when the results were adjusted for sex, age, pubertal stage and total body fat mass. Further investigations are necessary to verify the possible link between the mechanisms responsible for changes in hormonal and body fat distribution, from childhood to adolescence that may be responsible for the observed differences in the risk of higher %TF and IAF, in males and females, respectively, in the development of NAFLD.
Nonalcoholic fatty liver disease
Body Mass Index
High density lipoprotein-cholesterol
Low density lipoprotein-cholesterol
Subcutaneous abdominal fat tissue thickness
Intra-abdominal fat tissue thickness
Percentage of trunk fat
Trunk fat mass
Systolic blood pressure
Diastolic blood pressure
Tarantino G, Saldalamacchia G, Conca P, Arena A: Non-alcoholic fatty liver disease: Further expression of the metabolic syndrome. J Gastroenterol Hepatol. 2007, 22: 293-303. 10.1111/j.1440-1746.2007.04824.x.
Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C: Prevalence of fatty liver in children and adolescents. Pediatrics. 2006, 118: 1388-1393. 10.1542/peds.2006-1212.
Padoin AV, Staub HL, Chatkin JM, Moreto M, Maggioni L, Rizzolli J, Mottin CC: Doença hepática não-alcoólica gordurosa e risco de cirrose. Scientia Medica. 2008, 18: 172-176.
Damaso AR, do Prado WL, de Piano A, Tock L, Caranti DA, Lofrano MC, Carnier J, Cristofalo DJM, Lederman H, Tufik S, de Mello MT: Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents. Dig Liver Dis. 2008, 40: 132-139. 10.1016/j.dld.2007.09.009.
Chuang JH, Wang PW, Tai MH: An adipocentric view of liver fibrosis and cirrhosis. Chang Gung Med J. 2004, 27: 855-868.
Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE: Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008, 28: 13-24. 10.1111/j.1365-2036.2008.03703.x.
Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B: Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009, 29: 159-163. 10.1111/j.1478-3231.2008.01790.x.
Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE: Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006, 43: 413-427. 10.1097/01.mpg.0000239995.58388.56.
Clark JM, Brancati FL, Diehl AM: Nonalcoholic fatty liver disease. Gastroenterology. 2002, 122: 1649-1657. 10.1053/gast.2002.33573.
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000, 320: 1240-1243. 10.1136/bmj.320.7244.1240.
Freitas IF: Padronização de técnica antropométricas. 2008, São Paulo: Cultura Acadêmica
Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970, 45: 13-23. 10.1136/adc.45.239.13.
World Health Organization Expert Committee: Physical Status, the Use and Interpretation of Anthropometry. 1995, Geneva, Switzerland: World Health Organization, 263-311.
Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R: Ultrasonographic Quantitative Estimation of Hepatic Steatosis in Children with Nonalcoholic Fatty Liver Disease (DGNAF). J Pediatr Gastroenterol Nutr. 2011, 53: 190-195. 10.1097/MPG.0b013e31821b4b61.
Human RP, Jones GA: Evaluation of swab transport systems against a published standard. J Clin Pathol. 2004, 57: 762-763. 10.1136/jcp.2004.016725.
Christofaro DG, Casonatto J, Polito MD: Evaluation of the Omron MX3 Plus monitor for blood pressure measurement in adolescents. Eur J Pediatr. 2009, 168: 1349-1354. 10.1007/s00431-009-0936-x.
Must A, Dallal GE, Dietz WH: Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Am J C/in Nuir. 1991, 53: 46-839.
World Health Organization: Definition, diagnosis and Classification of diabetes mellitus and its complications. 1999, Genebra: Report of WHO a Consultation. Part 1:diagnosis and classification of diabetes meçlitus
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The Fourth Report on the Diagnosis,Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics. 2004, 114: 76-555.
de Piano A, Prado WL, Caranti DA, Siqueira KO, Stella SG, Lofrano M, Tock L, Cristofalo DMJ, Lederman H, Tufik S, de Melo MT, Dâmaso AR: Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2007, 44: 446-452. 10.1097/MPG.0b013e31803815d9.
Lavine JE, Schwimmer JB: Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis. 2004, 8: 549-558. 10.1016/j.cld.2004.04.010.
Rashid M, Roberts EA: Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000, 30: 48-53. 10.1097/00005176-200001000-00017.
Dixon JB, Bhathal PS, O'Brien PE: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001, 121: 91-100. 10.1053/gast.2001.25540.
Kimata H: Increased incidence of fatty liver in non-obese Japanese children under 1 year of age with or without atopic dermatitis. Public Health. 2006, 120: 176-178. 10.1016/j.puhe.2005.02.006.
Clark JM, Bancati FL, Diehl AM: Nonalcoholic fatty liver disease. Gastroenterology. 2002, 122: 1649-1657. 10.1053/gast.2002.33573.
Elbers JM, Asscheman H, Seidell JC, Gooren LJ: Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol. 1999, 276: 317-325.
Haarbo J, Marslew U, Gotfredsen A, Christiansen C: Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 1991, 40: 1323-1326. 10.1016/0026-0495(91)90037-W.
Toth MJ, Tchernof A, Sites CK, Poehlman ET: Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord. 2000, 24: 226-231. 10.1038/sj.ijo.0801118.
Fishbein MH, Mogren C, Gleason T, Stevens WR: Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2006, 42: 83-88.
Nakao K, Nakata K, Ohtsubo N, Maeda M, Moriuchi T, Ichikawa T, Hamasaki K, Kato Y, Eguchi K, Yukawa K, Ishii N: Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults. Am J Gastroenterol. 2002, 97: 1796-1801. 10.1111/j.1572-0241.2002.05846.x.
The authors declare that they have no competing interests.
PAM: (1) conception and design of the study, (2) acquisition, analysis and interpretation of data, (3) draft of the article and selection of manuscripts to discuss the results, JM, LSS, SAU, BMMA: (1) Acquisition, analysis and interpretation of data, (2) draft of the article and selection of manuscripts to discuss the results, RAF and IFFJ: (1) conception and design of the study (2) review and approval of the final version to be submitted. All authors read and approved the final manuscript.
About this article
Cite this article
Monteiro, P.A., Mota, J., Silveira, L.S. et al. Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study. BMC Res Notes 6, 89 (2013). https://doi.org/10.1186/1756-0500-6-89
- Nonalcoholic fatty liver disease